Here at Silicon Canals, we have extensively covered the factors contributing to the success of a startup. While most people believe that the idea is the most crucial factor, there’s survey data that indicates otherwise. One startup that did rather well and caught everyone’s attention early on is Medopad. The UK-based healthtech company has raised over $50 million (€46 million approx.) till date and now, it has made some new announcements.
Medopad rebrands to Huma
The UK-based healthtech startup is now rebranding to Huma. The company believes that this rebranding is impertinent for reflecting its commitment and mission as its services now go beyond remote patient monitoring and into digital biomarkers and therapeutics. The company was founded in 2011 by Dan Vahdat and Rich Khatib. Partnering with scientists, healthcare and pharmaceutical professionals, and technologists, the company builds proactive healthcare solutions via a portfolio of DTx and digital biomarkers.